TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 87 filers reported holding TG THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 3.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,709,000 | -91.5% | 195,212 | -85.1% | 0.01% | -92.4% |
| Q3 2021 | $43,723,000 | -60.1% | 1,313,788 | -53.5% | 0.10% | -60.2% |
| Q2 2021 | $109,650,000 | -51.5% | 2,826,762 | -39.8% | 0.26% | -54.2% |
| Q1 2021 | $226,314,000 | -2.0% | 4,695,301 | +5.7% | 0.58% | -5.4% |
| Q4 2020 | $230,993,000 | +72.7% | 4,440,459 | -11.2% | 0.61% | +42.9% |
| Q3 2020 | $133,761,000 | +417.6% | 4,998,526 | +276.8% | 0.43% | +374.4% |
| Q2 2020 | $25,844,000 | +177.7% | 1,326,685 | +40.3% | 0.09% | +119.5% |
| Q1 2020 | $9,306,000 | +293.2% | 945,764 | +302.7% | 0.04% | +485.7% |
| Q3 2015 | $2,367,000 | -63.7% | 234,829 | -40.3% | 0.01% | -58.8% |
| Q2 2015 | $6,525,000 | – | 393,308 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |